The global metabolomics market is experiencing robust growth, driven by increasing applications in life sciences, precision medicine, and drug discovery. According to Kings Research, the market was valued at USD 2,687.2 million in 2023 and is projected to grow from USD 3,074.5 million in 2024 to USD 8,939.8 million by 2031, exhibiting an impressive CAGR of 16.47% during the forecast period. Get...